JuneYao Health "Qingyou" series products are in short supply

Recently, the US Department of Health and Human Services released the 15th edition of the carcinogen report, listing the chronic infection of Helicobacter pylori as a clear carcinogen, and the CCTV network also reported the news. Subsequently, the topic #Helicobacter pylori in the United States as a clear carcinogen # appeared on the hot search lists of major platforms.

Affected by this news, JuneYao Health has risen and fallen for two consecutive days on Wednesday and Thursday. It is reported that JuneYao Health has the exclusive right to use Jiangnan University's patent "Lactobacillus curridocus CFM1118 for the prevention and/or treatment of Helicobacter pylori infection", and the products using this strain have just appeared at the 4th CIIE and Boao Entrepreneurs Forum.

Helicobacter pylori infection is a chronic and long-term process that is generally difficult for the body to clear spontaneously after infection. In recent years, Through a large number of experimental studies, Jiangnan University has discovered that anti-globinotherapy - bacteriostatic, through Lactobacillus currier CFM1118, prevention and/or treatment of Helicobacter pylori infection. The strain has obtained the Chinese invention patent certificate (patent number: ZL 2020 1 0479611.4), the clinical comparison experimental data published in the patent specification shows that Lactobacillus currier cIFM1118 can significantly reduce the degree of helicobacter pylori infection in patients, inhibit the growth of Helicobacter pylori and reduce its adhesion rate and colonization in the patient.

It is understood that Jiangnan University will exclusively authorize Lactobacillus currier CFM1118 to JuneYao Health. In March 2021, the two sides have established a long-term strategic cooperation and established a joint innovation laboratory, JuneYao Health has obtained the exclusive right to use the core strains of Jiangnan University, and at present, Lactobacillus currier CFM1118 and patented technology have been industrialized in JuneYao Health, and the "Qingyou" series of products is in short supply. Different from the common probiotic powders on the market, JuneYao Health applies this strain to easy-to-carry and easy-to-eat probiotic carriers such as chewable tablets and chocolates, and in July 2021, it has successively launched "Qingyou Shuang" lactic acid bacteria drinks, "Qing Youshuang" compound probiotic chewable tablets, and "Qing Youjun" yogurt active probiotics and other probiotic products in November. In the past few months of listing, the "Qingyou" series has gained many fans on social platforms such as Xiaohongshu and Douyin. Offline supermarkets and distribution stores, the "Qingyou" series is displayed in a conspicuous position.

"Powder is easy to choke on, and we've made it easier to eat through innovations in probiotic form." At the same time, the application of low-temperature freezing technology and three-layer embedding technology achieved a 98% intestinal survival rate of live bacteria, overcoming the problem of 'gastric acid barrier'. According to the person in charge of JuneYao Health. (In painting)